THE TREATMENT OF LIVER METASTASES FROM COLORECTAL CANCER: QUESTIONS MORE THAN ANSWERS?

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

BIASCO G.; DERENZINI E.; DI BATTISTA M.; BRANDI G.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: GOVARESH JOURNAL Year:2004 | Volume:9 | Issue:2 Page(s): 132-141

Download Full-Text

View:

364

Download:

Cites:

Information Journal Paper

Title

THE TREATMENT OF LIVER METASTASES FROM COLORECTAL CANCER: QUESTIONS MORE THAN ANSWERS?

Author(s)

BIASCO G. | DERENZINI E. | DI BATTISTA M. | BRANDI G. | Issue Writer Certificate

Keywords

COLORECTAL CANCER

LIVER METASTASES

5-FLUOROURACIL

OXALIPLATIN

IRINOTECAN

Abstract

About 50% of all patients affected by CRC develop LIVER METASTASES. Surgery remains the only potentially curative strategy, but is impossible in the majority of patients. For non-resectable patients, two options are available: local treatment strategies (radiofrequency ablation and cryosurgery: alone or in combination with surgery) and chemotherapy. High rates of objective response achieved with Fluoropyrimidines, OXALIPLATIN (OHP) and IRINOTECAN (CPT-11) based chemotherapy, enable initially non-resectable patients to undergo surgery, with a 5-year survival rate comparable to that observed for primary resectable patients. Therefore, chemotherapy has not only a palliative aim, but becomes a strategy with curative purposes. Adjuvant therapies have been investigated to reduce recurrence rates, some testing hepatic arterial infusion (HAI) schedules but definitive data are not yet available. Our experience, based on results from retrospective studies, suggests a possible role of systemic adjuvant chemotherapy in reducing recurrence rates after surgery. New targeted drugs and new loco-regional therapies are expected to further improve prognosis in neoadjuvant, adjuvant and palliative settings

Cites

No record.

References

No record.

Cite

APA: Copy

BIASCO, G., DERENZINI, E., DI BATTISTA, M., & BRANDI, G.. (2004). THE TREATMENT OF LIVER METASTASES FROM COLORECTAL CANCER: QUESTIONS MORE THAN ANSWERS?. GOVARESH JOURNAL, 9(2), 132-141. SID. https://sid.ir/paper/527951/en

Vancouver: Copy

BIASCO G., DERENZINI E., DI BATTISTA M., BRANDI G.. THE TREATMENT OF LIVER METASTASES FROM COLORECTAL CANCER: QUESTIONS MORE THAN ANSWERS?. GOVARESH JOURNAL[Internet]. 2004;9(2):132-141. Available from: https://sid.ir/paper/527951/en

IEEE: Copy

G. BIASCO, E. DERENZINI, M. DI BATTISTA, and G. BRANDI, “THE TREATMENT OF LIVER METASTASES FROM COLORECTAL CANCER: QUESTIONS MORE THAN ANSWERS?,” GOVARESH JOURNAL, vol. 9, no. 2, pp. 132–141, 2004, [Online]. Available: https://sid.ir/paper/527951/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops